Showing 1 - 10 of 91
The COVID-19 pandemic has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Despite rapid development of a range of COVID-19 vaccines using innovative technologies, access to these vaccines has been a challenge, with manufacturing mostly...
Persistent link: https://www.econbiz.de/10014578934
Persistent link: https://www.econbiz.de/10002088719
Persistent link: https://www.econbiz.de/10002797059
Persistent link: https://www.econbiz.de/10012800211
Persistent link: https://www.econbiz.de/10013179222
To overcome the problem of insufficient research and development (Ramp;D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...
Persistent link: https://www.econbiz.de/10012751417
To overcome the problem of insufficient research and development (R&D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...
Persistent link: https://www.econbiz.de/10012467396
Persistent link: https://www.econbiz.de/10011954023
COVID-19 has had a devastating effect on the ASEAN region, which has recorded over 27 million cases of the virus. Access to COVID-19 vaccination has significantly reduced the spread of the disease and limited the number of severe COVID-19 cases, but it has also impacted routine immunization...
Persistent link: https://www.econbiz.de/10014579069
COVID-19 has devastated the ASEAN region, threatening two decades of human and economic development gains. With a population of more than 600 million, the region has reported more than 13 million COVID-19 cases as of October 2021, with Indonesia, the Philippines, Malaysia, and Thailand leading...
Persistent link: https://www.econbiz.de/10014579228